Table 1.
nPOD donors genotyped by UFDIchip.
| Clinical Group | Female | Male | Black/African American | American Indian/Alaska Native | Asian | White/Caucasian | Hispanic/Latinx | Multiracial | Age (Median [IQR]) | Diabetes Duration (Median [IQR]) |
|---|---|---|---|---|---|---|---|---|---|---|
| No Diabetes | 50 | 97 | 30 | 1 | 1 | 93 | 20 | 2 | 15.20 [3.9–25.9] | N/A |
| AAb + | 12 | 14 | 2 | 0 | 0 | 18 | 6 | 0 | 25.17 [21.0–38.5] | N/A |
| T1D | 52 | 59 | 16 | 0 | 0 | 86 | 9 | 0 | 26.00 [19.1–33.9] | 11.00 [5.0–20.0] |
| T1D Medalist | 1 | 1 | 0 | 0 | 0 | 2 | 0 | 0 | 69.00 [64.5–73.5] | 66.50 [62.8–70.2] |
| Transplant | 1 | 4 | 0 | 0 | 0 | 5 | 0 | 0 | 52.00 [47.0–55.3] | 38.00 [26.0–40.0] |
| T2D | 18 | 20 | 11 | 0 | 2 | 17 | 8 | 0 | 48.90 [45.0–60.0] | 10.00 [3.0–15.0] |
| Gastric Bypass | 2 | 0 | 0 | 0 | 0 | 2 | 0 | 0 | 42.00 [39.0–45.0] | 3.00 [3.0–3.0] |
| Gestational Diabetes | 4 | 0 | 1 | 0 | 0 | 2 | 1 | 0 | 33.35 [32.2–33.9] | 0.06 [0.1–0.1] |
| Monogenic Diabetes | 2 | 2 | 1 | 0 | 0 | 2 | 1 | 0 | 33.55 [24.6–41.7] | 17.50 [12.0–22.0] |
| Cystic Fibrosis | 3 | 2 | 0 | 0 | 0 | 4 | 1 | 0 | 31.10 [29.3–33.0] | 5.00 [2.0–7.0] |
| Other-Diabetes | 6 | 6 | 2 | 0 | 0 | 7 | 3 | 0 | 33.95 [26.0–44.5] | 4.00 [2.0–13.5] |
| Other-No Diabetes | 6 | 6 | 0 | 0 | 1 | 8 | 3 | 0 | 17.52 [14.8–23.0] | N/A |
| Pregnancy | 4 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 29.45 [21.4–37.0] | N/A |
| Total | 161 | 211 | 65 | 2 | 5 | 246 | 52 | 2 |
Data are presented as number of male and female donors and number of donors per reported race/ethnicity for each clinical group, along with age (years) and diabetes duration (years). AAb+ : islet autoantibody positive without T1D, T1D: Type 1 diabetes, T1D Medalist: T1D duration > 50 years15,16, Transplant: Medical history of T1D and pancreas transplant recipient, T2D: Type 2 diabetes, N/A: not applicable, IQR: interquartile range.